Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0868
Abstract: This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization. read more here.
Keywords: bnt162b2; ad26 cov2; covid; vaccine ... See more keywords
Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27629
Abstract: In March, people living with HIV infection (PLWH) were included in the risk category of fragile people for severe COVID‐19 receiving priority access to vaccination with BNT162b2 vaccine. The aim of the study was to… read more here.
Keywords: time; bnt162b2; mrna vaccine; immunogenicity safety ... See more keywords
Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28032
Abstract: SARS‐CoV‐2 vaccines have contributed to the control of COVID‐19 in some parts of the world. However, the constant emergence of variants of concern (VOCs) challenges the effectiveness of SARS‐CoV‐2 vaccines over time. In particular, Omicron… read more here.
Keywords: mrna 1273; neutralizing antibodies; bnt162b2; ad26 cov2 ... See more keywords
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Sign Up to like & getrecommendations! Published in 2024 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-024-00927-0
Abstract: Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participants before and after BNT162b2 vaccination.… read more here.
Keywords: year; year olds; troponin levels; vaccination ... See more keywords
Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults
Sign Up to like & getrecommendations! Published in 2024 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-024-01005-1
Abstract: Recent data have shown elevated infection rates in several subpopulations at risk of SARS-CoV-2 infection and COVID-19, including immunocompromised (IC) individuals. Previous research suggests that IC persons have reduced risks of hospitalization and medically attended… read more here.
Keywords: attended covid; mrna 1273; medically attended; third dose ... See more keywords
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.05.021
Abstract: Objective We herein report the initial impact of a national BNT162b2 rollout on SARS-CoV-2 infections in Qatar. Methods We included all individuals who by 16 March 2021 had completed ≥14 days of follow up after… read more here.
Keywords: bnt162b2; impact national; national bnt162b2; sars cov ... See more keywords
Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
Sign Up to like & getrecommendations! Published in 2022 at "iScience"
DOI: 10.1016/j.isci.2021.103694
Abstract: Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of this regimen.… read more here.
Keywords: chadox1 ncov; bnt162b2; sars cov; vaccination ... See more keywords
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Epidemiology"
DOI: 10.1093/ije/dyac199
Abstract: Abstract Background Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospitalization and death. However, some evidence suggests that notable waning in effectiveness against these outcomes occurs within months of vaccination. We undertook… read more here.
Keywords: first second; bnt162b2; covid; target trial ... See more keywords
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the Pediatric Infectious Diseases Society"
DOI: 10.1093/jpids/piad015
Abstract: Abstract In this ongoing study, substantially increased ancestral SARS-CoV-2 neutralizing responses were observed 1 month after a third 10-µg BNT162b2 dose given to 5 to 11-year olds versus neutralizing responses post-dose 2. After dose 3,… read more here.
Keywords: immunogenicity safety; year olds; bnt162b2; neutralizing responses ... See more keywords
An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004105
Abstract: Background. Severe acute respiratory syndrome coronavirus 2 is associated with high mortality among transplant recipients. Comparative data that define humoral responses to the Oxford-AstraZeneca (AZ) and BNT162b2 (Pfizer-BioNTech) vaccines are limited. Methods. We recruited 920… read more here.
Keywords: bnt162b2; pfizer; oxford astrazeneca; pfizer biontech ... See more keywords
Relative effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines and homologous boosting in preventing COVID-19 in adults in the US
Sign Up to like & getrecommendations! Published in 2023 at "Open Forum Infectious Diseases"
DOI: 10.1101/2023.02.10.23285603
Abstract: Background: Few head-to-head comparisons have been performed on the real-world effectiveness of COVID-19 booster vaccines. We evaluated the relative effectiveness (rVE) of a primary series of mRNA-1273 versus BNT162b2 and Ad26.COV2.S and a homologous mRNA… read more here.
Keywords: mrna 1273; mrna; bnt162b2; covid ... See more keywords